STAMICIS

This brand name is authorized in Austria, Estonia, France, Hong Kong SAR China, Ireland, Malta, Singapore, Spain, UK.

Active ingredients

The drug STAMICIS contains one active pharmaceutical ingredient (API):

1
UNII N6OU7HJ70P - TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
 

Technetium 99mTc sestamibi is a coordination complex consisting of the radioisotope technetium-99m bound to six methoxyisobutylisonitrile (MIBI) ligands, hence the name sesta (6) MIBI. Following intravenous injection of the drug, Technetium 99mTc sestamibi is taken up by the myocardium, parathyroid, and/or breast tissue.

 
Read more about Technetium ⁹⁹ᵐTc sestamibi

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 STAMICIS Kit for radiopharmaceutical preparation MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V09GA01 Technetium (99mTc) sestamibi V Various → V09 Diagnostic radiopharmaceuticals → V09G Cardiovascular system → V09GA Technetium (99mTc) compounds
Discover more medicines within V09GA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1393983
ES Centro de información online de medicamentos de la AEMPS 71081
FR Base de données publique des médicaments 65679296
GB Medicines & Healthcare Products Regulatory Agency 395348
HK Department of Health Drug Office 57910
MT Medicines Authority AA826/00202
SG Health Sciences Authority 14129P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.